Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medifocus Inc MDFZF

Medifocus Inc develops and sells minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostate Hyperplasia (BHP). It owns two focused heat technology platforms, The Endo-thermotherapy Platform-from which Prolieve was developed, can be used to treat cancers in prostate, rectal, cervical and esophageal, and The... see more

EXPM:MDFZF - Post Discussion

Medifocus Inc > MFS-TSXV Looks like rumour with something with Covid-19
View:
Post by Hodo25 on Apr 23, 2020 11:30am

MFS-TSXV Looks like rumour with something with Covid-19

MAYBE THEY HAVE SOMETHING THAT WILL HELP WITH COVID-19.  @.015-.02 CENTS WORTH A CHANCE AT A GAMBLE.  COULD GET AT LEAST A DBL MAYBE BY TOMORROW.
Comment by Chas15 on Apr 23, 2020 11:53am
A ton of volume, definitely has my attention. Maybe their heat system is useful to COVID detection? Worth a gamble imo. 
Comment by U2CanBHappy on Apr 23, 2020 11:55am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities